Effects of the lupus anticoagulant on the control of oral anticoagulant treatment [7]

British Journal of Haematology

Volumn 124, Issue 4, 2004, Pages 562-563

  Carrasco, C ^a   Campbell, B ^a   Shiach, C ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Lupus anticoagulant; Point of care testing device

Indexed keywords

ANTICOAGULANT AGENT; LUPUS ANTICOAGULANT; THROMBOPLASTIN; WARFARIN;

ADULT; ANAMNESIS; ANTICOAGULANT THERAPY; ANTICOAGULATION; CASE REPORT; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTERNATIONAL STANDARD UNIT; LETTER; PRIORITY JOURNAL; THROMBOPLASTIN TIME;

ANTICOAGULANTS; DRUG MONITORING; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; LUPUS COAGULATION INHIBITOR; MIDDLE AGED; POINT-OF-CARE SYSTEMS; WARFARIN;

EID: 1242338011     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.04813.x     Document Type: Letter

References (4)

1. Douketis, J.D., Lane, A., Milne, J. & Ginsberg, J. (1998) Accuracy of a portable international ratio monitor in outpatients receiving long-term oral anticoagulant therapy: comparison with a laboratory reference standard using clinically relevant criteria for agreement. Thrombosis Research, 92, 11-17.
2. Moll, S. & Ortel, T.L. (1997) Monitoring warfarin therapy in patients with lupus anticoagulants. Annals of Internal Medicine, 127, 177-178.
3. Tripodi, A., Chantarangkul, V., Clerici, M., Negri, B., Galli, M. & Mannucci, P.M. (2001) Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastins. British Journal of Haematology, 115, 672-678.
4. Van den Besselar (2000) A comparison of INRs determined with a whole blood prothrombin time. Thrombosis and Haemostasis, 84, 410-412.